Zuzana Tothova, MD, PhD

Assistant Professor of Medicine, Dana-Farber Cancer Institute
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.
Authors: Authors: Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE.
Nat Biotechnol
View full abstract on Pubmed
NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a.
Authors: Authors: Gu TL, Tothova Z, Scheijen B, Griffin JD, Gilliland DG, Sternberg DW.
Blood
View full abstract on Pubmed
Hemophagocytic Syndrome and Critical Illness: New Insights into Diagnosis and Management.
Authors: Authors: Tothova Z, Berliner N.
J Intensive Care Med
View full abstract on Pubmed